PMID- 22253710 OWN - NLM STAT- MEDLINE DCOM- 20120529 LR - 20211021 IS - 1932-6203 (Electronic) IS - 1932-6203 (Linking) VI - 7 IP - 1 DP - 2012 TI - Effects of Astragalus polysaccharide on immune responses of porcine PBMC stimulated with PRRSV or CSFV. PG - e29320 LID - 10.1371/journal.pone.0029320 [doi] LID - e29320 AB - BACKGROUND: Astragalus polysaccharide (APS) has been used as an immunomodulator that can enhance immune responses, whereas the immunomodulatory effects of APS on porcine peripheral blood mononuclear cells (PBMCs) exposed to porcine reproductive and respiratory syndrome virus (PRRSV) and classical swine fever virus (CSFV) have not been investigated. METHODOLOGY/PRINCIPAL FINDINGS: Porcine PBMCs were cultured in complete RPMI media in the presence of the R98-strain of PRRSV (5x10(4) TCID(50)/ml) or C-strain of CSFV (10(3) TCID(50)/ml) with or without APS. The expression of mRNA for CD28, cytotoxic T-lymphocyte antigen 4 (CTLA-4), transforming growth factor-beta (TGF-beta), interleukin 2 (IL-2) and IL-10 was assayed by TaqMan real-time RT-PCR. The expression of mRNA for CD28 and CTLA-4 increased at 24 h after stimulation of PBMCs with CSFV and the increased production of CTLA-4 was confirmed by western blot analysis, whereas the increases were inhibited by the addition of APS. In addition, APS alone upregulated IL-2 and TGF-beta mRNA expression in PBMCs and the addition of APS had the capacity to prevent a further increase in IL-2 mRNA expression in PBMCs during CSFV or PRRSV infection, but had no effect on TGF-beta mRNA expression. The production of tumor necrosis factor-alpha (TNF-alpha) increased at 12 h after stimulation with PRRSV or CSFV, but not with PRRSV plus APS or CSFV plus APS, whereas the addition of APS to PBMCs infected with PRRSV or CSFV promoted IL-10 mRNA expression. CONCLUSIONS: We suggested that APS had immunomodulatory effects on cells exposed to PRRSV or CSFV. It might be that APS via different mechanisms affects the activities of immune cells during either PRRSV or CSFV infection. This possibility warrants further studies to evaluate whether APS would be an effective adjuvant in vaccines against PRRSV or CSFV. FAU - Zhuge, Zeng-Yu AU - Zhuge ZY AD - College of Veterinary Medicine, China Agricultural University, Beijing, China. FAU - Zhu, Yao-Hong AU - Zhu YH FAU - Liu, Pan-Qi AU - Liu PQ FAU - Yan, Xiao-Dong AU - Yan XD FAU - Yue, Yuan AU - Yue Y FAU - Weng, Xiao-Gang AU - Weng XG FAU - Zhang, Rong AU - Zhang R FAU - Wang, Jiu-Feng AU - Wang JF LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20120109 PL - United States TA - PLoS One JT - PloS one JID - 101285081 RN - 0 (CD28 Antigens) RN - 0 (CTLA-4 Antigen) RN - 0 (Cytokines) RN - 0 (Polysaccharides) RN - 0 (RNA, Messenger) SB - IM MH - Animals MH - CD28 Antigens/genetics/metabolism MH - CTLA-4 Antigen/genetics/metabolism MH - Cell Proliferation/drug effects MH - Classical Swine Fever Virus/drug effects/*immunology MH - Cytokines/genetics/metabolism MH - Enzyme-Linked Immunosorbent Assay MH - Gene Expression Regulation/drug effects MH - Immunity/*drug effects MH - Leukocytes, Mononuclear/drug effects/*immunology/pathology MH - Lymphocyte Activation/drug effects MH - Polysaccharides/*pharmacology MH - Porcine respiratory and reproductive syndrome virus/drug effects/*immunology MH - RNA, Messenger/genetics/metabolism MH - Subcellular Fractions/drug effects/metabolism MH - Sus scrofa/*immunology/*virology PMC - PMC3253776 COIS- Competing Interests: The authors have declared that no competing interests exist. EDAT- 2012/01/19 06:00 MHDA- 2012/05/30 06:00 PMCR- 2012/01/09 CRDT- 2012/01/19 06:00 PHST- 2011/06/20 00:00 [received] PHST- 2011/11/24 00:00 [accepted] PHST- 2012/01/19 06:00 [entrez] PHST- 2012/01/19 06:00 [pubmed] PHST- 2012/05/30 06:00 [medline] PHST- 2012/01/09 00:00 [pmc-release] AID - PONE-D-11-11290 [pii] AID - 10.1371/journal.pone.0029320 [doi] PST - ppublish SO - PLoS One. 2012;7(1):e29320. doi: 10.1371/journal.pone.0029320. Epub 2012 Jan 9.